Skip to main content
. 2020 Oct 28;6(2):159–167. doi: 10.1001/jamacardio.2020.4909

Table 3. Multivariable Cox Proportional Hazards Regression Model for Mortality After Heart Transplant.

Covariate Hazard ratio (95% CI) P value
Transplant after policy change 1.29 (1.07-1.55) .008
Age (increasing, per 1 y) 1.01 (1.00-1.02) .003
BMI (increasing, per 1 U) 1.02 (1.00-1.03) .03
Heart failure cause
Nonischemic dilated cardiomyopathy 1 [Reference] NA
Ischemic cardiomyopathy 1.20 (1.03-1.40) .02
Congenital heart disease 2.12 (1.45-3.10) <.001
Restrictive cardiomyopathy 1.46 (1.07-1.99) .02
Valvular heart disease 0.78 (0.38-1.62) .51
Failed primary heart transplant 2.38 (1.67-3.41) <.001
Hypertrophic cardiomyopathy 0.99 (0.64-1.54) .97
Diabetes 1.18 (1.02-1.36) .03
Serum total bilirubin (increasing, per 1 mg/dL) 1.04 (1.03-1.06) <.001
Serum creatinine (increasing, per 1 mg/dL) 1.06 (1.01-1.11) .02
Recipient cytomegalovirus positive 1.12 (0.98-1.29) .09
Pretransplant mechanical ventilatory support 1.50 (0.97-2.32) .07
Extracorporeal membrane oxygenation 1.90 (1.31-2.78) .001
Bridging with ventricular assist device
None 1 [Reference] NA
Left ventricular assist device 1.22 (1.05-1.41) .008
Right ventricular assist device 2.63 (1.07-6.48) .04
Total artificial heart 2.71 (1.69-4.35) <.001
Biventricular assist device 1.39 (0.86-2.25) .18
Donor age (increasing, per 1 y) 1.01 (1.01-1.02) <.001
Ischemic time (increasing, per 1 h) 1.13 (1.06-1.20) <.001

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); NA, not applicable.